Bayer, a German multinational pharmaceutical and life sciences company, and Haplogen GmbH, a Vienna-based biotechnology company, announced yesterday that they have entered into a multi-year research collaboration agreement to identify new drug candidates for the treatment of pulmonary diseases
such as chronic obstructive pulmonary disease
for POL6014, a clinical stage selective inhibitor of human neutrophil elastase with the potential to treat cystic fibrosis (CF) and other neutrophilic pulmonary diseases
such as non-cystic fibrosis bronchiectasis (NCFB), alpha-1 antitrypsin deficiency (AATD) and primary ciliary dyskinesia (PCD).
Kosta Kostov, a national consultant for pulmonary diseases
, told BNR.
Echocardiography in chronic obstructive pulmonary diseases
Japanese researchers have found that abnormal delivery of zinc to lung cells contributes to obstructive pulmonary diseases
, a collective term for refractory respiratory diseases with chronic airway inflammation and excessive mucus retention that are accompanied by airway obstruction.
Methods: We analysed 194 patients admitted for acute exacerbation of chronic obstructive pulmonary disease
at The Institute for Pulmonary Diseases
of Vojvodina, Sremska Kamenica, Serbia.
24 -- Alarming rates of pulmonary diseases
in India are warranting urgent action as well as well-coordinated and inter-sectoral comprehensive health responses across the country to ensure every citizen enjoys lung health.
Louis present 28 chapters that cover chest radiographs and computed tomography, pulmonary function testing, fiberoptic bronchoscopy, noninvasive ventilation, and various pulmonary diseases
and conditions, such as asthma, cough, chronic obstructive pulmonary disease
, pneumonia, infections, cystic fibrosis, and sleep-disordered breathing, as well as smoking cessation and lung transplantation.
Methods: The retrospective study was conducted at Yuzuncuy?l University, Van, Turkey, and comprised record of in- patients with moderate to severe chronic obstructive pulmonary disease
who required invasive mechanical ventilation in the intensive care unit of the Pulmonary Diseases
Department between January 2007 and December 2010.
Capsugel and Pulmatrix have formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases
. The agreement provides Capsugel exclusive rights to manufacture clinical trial and commercial batches of iSPERSE-based inhaled therapeutic candidates being developed by Pulmatrix and its potential development partners.
(SeeNews) - Jul 1, 2014 - Belgian biotechnology firmA GalapagosA (EBR:GLPG) said Tuesday it would start a Phase I clinical trial with the GLPG1690 molecule aimed at treating pulmonary diseases